Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Developmental Support Program: A Intervention Study

15 de junho de 2026 atualizado por: Pınar Ateş, TC Erciyes University

The Effect of a Developmental Support Program for Parents of Children Aged 1-3 Years in a Family Health Center: An Interventional Study

This study aims to evaluate the effectiveness of an online video-based developmental support program for parents of children aged 1-3 years receiving care at a Family Health Center. Approximately 60 parents will be randomly assigned to either an intervention group, which will receive a four-week online developmental support program, or a control group, which will continue to receive usual healthcare services. Data will be collected at baseline, two weeks after the intervention, and at one- and three-month follow-up assessments. The study will examine the effects of the online video-based developmental support program on parents' attitudes toward child development, developmental awareness, parenting self-efficacy, and the quality of the home environment that supports child development.

Visão geral do estudo

Status

Ainda não está recrutando

Descrição detalhada

Study Design This study is a randomized controlled, parallel-group experimental trial with pre-test and post-test measurements.

Study Setting The study will be conducted at Şeyh Şamil Family Health Center, one of the Family Health Centers affiliated with the Sivas Provincial Health Directorate. The center was selected because it serves the highest number of children aged 12-36 months among the eligible centers. Child development is monitored according to the Infant, Child, and Adolescent Follow-up Protocol of the General Directorate of Public Health. Nurses provide developmental screening, immunization, anthropometric measurements, risk assessment, early intervention activities, and parental counseling services.

Population and Sample The study population consists of 310 parents with children aged 12-36 months. The sample size was calculated using G*Power version 3.1.9.4 software. Based on Cohen's criteria, a medium effect size (Cohen's d = 0.5), a 95% confidence level (α = 0.05), and 80% statistical power (1 - β = 0.80) were used. Accordingly, a minimum of 30 participants per group (total sample size = 60) was required for an independent samples t-test design. Considering a potential attrition rate of 20%, the final sample size was determined as 60 participants. Participants will be randomly assigned to either the intervention group (n = 30) or the control group (n = 30).

Eligibility Criteria Inclusion Criteria

  • Being the parent of a child aged 12-36 months
  • Child's growth percentile being between the 3rd and 97th percentiles
  • Ability to speak and understand Turkish
  • No prior participation in a similar developmental support program
  • Having internet access and the ability to use a computer, tablet, or smartphone
  • Completion of at least primary school education
  • Ability to read and understand written materials
  • Willingness to participate in the study Exclusion Criteria
  • Missing at least one session of the intervention program
  • Living in an extended family household
  • Experiencing a major psychosocial event within the last six months (e.g., relocation, death of a first-degree relative, or divorce)
  • Adolescent parenthood
  • Having a child with a history of congenital anomalies, chronic illness, or prematurity
  • Having a diagnosed mental health disorder Blinding Due to the nature of the intervention, participants and researchers cannot be blinded. However, statistical and reporting blinding will be implemented. Data will be coded without indicating group allocation, and statistical analyses will be conducted by an independent statistician.

Randomization Participants who meet the eligibility criteria will be assigned to either the intervention or control group using a simple randomization procedure conducted through an online randomization program.

Outcome Measures Primary Outcomes

  • Score on the Psychosocial Developmental Attitudes Scale for Ages 0-6
  • Score on the Mindful Parenting Scale
  • Score on the Parenting Self-Efficacy Scale
  • Score on the Home Observation and Measurement of the Environment Scale for Young Children Data Collection Instruments Data will be collected using the Family Information Form, the Psychosocial Developmental Attitudes Scale for Ages 0-6, the Mindful Parenting Scale, the Parenting Self-Efficacy Scale (Short Form), and the Home Observation and Measurement of the Environment Scale for Young Children.

Intervention Development The developmental support program will be developed based on a literature review and expert consultation. Content validity will be evaluated by experts in child development and pediatric nursing using the Davis technique. Each item will be rated on a four-point scale. A Content Validity Index (CVI) greater than 0.80 will be considered acceptable. The final program will consist of four modules, each containing two sessions. A pilot study involving five parents who are not included in the main study will be conducted to assess the feasibility of the intervention and the clarity of the data collection instruments. Revisions will be made based on participant feedback.

Intervention Procedures Participants in the intervention group will complete baseline assessments before receiving the developmental support program. The intervention will be delivered online over four weeks through video-supported sessions conducted via Zoom. Participants will attend one session per week in groups of approximately 15 parents. Each session will last 30-45 minutes. Process evaluation forms will be used to assess participation and satisfaction. Outcome measures will be repeated two weeks after program completion and at one-month and three-month follow-up assessments.

Control Group Participants in the control group will continue to receive routine primary healthcare services provided by the Family Health Center. Assessments will be conducted at the same time points as in the intervention group. After completion of the study, the developmental support program videos will be made available to participants in the control group.

Data Collection Methods Data will be collected through face-to-face interviews conducted either at the Family Health Center or in participants' homes. Written informed consent will be obtained before participation. Baseline, post-intervention, and follow-up assessments will be completed using standardized measurement instruments.

Data Analysis Data will be analyzed using IBM SPSS Statistics (Statistical Package for the Social Sciences). The normality of data distribution will be assessed using the Kolmogorov-Smirnov test and the Shapiro-Wilk test. For normally distributed data, independent samples t-tests and analysis of variance (ANOVA) will be used. For non-normally distributed data, the Mann-Whitney U test and Kruskal-Wallis test will be applied. Relationships between variables will be examined using Pearson correlation analysis or Spearman rank correlation analysis. Statistical significance will be defined as a p-value less than 0.05.

Tipo de estudo

Intervencional

Inscrição (Estimado)

60

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

  • Nome: Yağmur Sezer Efe, Assoc. Prof. Dr.
  • Número de telefone: +90 0507 437 85 62
  • E-mail: ysezerefe@gmail.com

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Sim

Descrição

Inclusion Criteria:

  • Parents with children aged 12-36 months
  • Children with a percentile value between the 3rd and 97th percentile
  • Able to speak and understand Turkish
  • No previous participation in a similar program
  • Having internet access and the ability to use a computer/laptop, tablet, or smartphone
  • At least primary school graduates
  • Able to read and comprehend written information
  • Willing to participate in the study

Exclusion Criteria:

  • Adolescent parents
  • Parents of children with congenital anomalies, chronic diseases, or a history of prematurity
  • Individuals with a diagnosed mental health disorder

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Pesquisa de serviços de saúde
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Triplo

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Salutogenic Model-Based Developmental Support Program
Parents in the experimental group will receive a 4-week video-based developmental support program delivered via Zoom. The program is based on the salutogenic model (comprehensibility, manageability, and meaningfulness) and aims to improve parental understanding of child development, parenting self-efficacy, and mindful parenting skills. The intervention consists of four weekly sessions delivered in groups of 15 participants, each lasting 30-45 minutes.
A 4-week video-based developmental support program delivered via Zoom for parents of children aged 12-36 months. The program is based on the salutogenic model (comprehensibility, manageability, meaningfulness). It includes four weekly group sessions (15 participants per group), each lasting 30-45 minutes. The program aims to improve parental understanding of child development and parenting skills.
Sem intervenção: Routine Care
Parents in the control group will continue to receive routine primary healthcare services provided at Family Health Centers, including standard child health monitoring, vaccinations, and counseling services. No additional educational or interventional program will be provided during the study period.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
0-6 Years Psychosocial Developmental Attitudes Scale
Prazo: From enrollment to 3 months after completion of the intervention

Total score of the 0-6 Years Psychosocial Developmental Attitudes Scale assessing parents' attitudes toward psychosocial development in early childhood.

The scale consists of 18 items rated on a 3-point Likert scale (1 = Disagree, 2 = Sometimes, 3 = Agree). The total score ranges from 18 to 54, with higher scores indicating a more positive and appropriate attitude toward supporting the psychosocial development of children aged 0-6 years.

Higher scores reflect more accurate and supportive parental attitudes toward child psychosocial development, while lower scores indicate less positive or less appropriate attitudes.

From enrollment to 3 months after completion of the intervention
Interpersonal Mindfulness in Parenting Questionnaire
Prazo: From enrollment to the end of the 3-month follow-up period after the interventio

The Interpersonal Mindfulness in Parenting Questionnaire (MIPQ) is a 24-item scale designed to assess parents' mindfulness in interactions with their children.

It consists of two subscales: Being in the Moment with the Child (11 items) and Mindful Discipline (13 items). Items are rated on a 4-point Likert scale ranging from 1 (rarely) to 4 (almost always). The total score ranges from 24 to 96.

Higher scores indicate higher levels of mindful parenting, reflecting greater awareness, emotional regulation, and present-moment attention in parent-child interactions. Lower scores indicate lower mindfulness in parenting behaviors.

The scale has no reverse-coded items. Reported internal consistency reliability is 0.87 for the total scale, 0.73 for the Being in the Moment subscale, and 0.83 for the Mindful Discipline subscale.

From enrollment to the end of the 3-month follow-up period after the interventio
Parenting Self-Efficacy Scale
Prazo: From enrollment to the end of the 3-month follow-up period after the intervention

The Parenting Self-Efficacy Scale (Short Form) is a questionnaire designed to assess parents' perceived self-efficacy in performing parenting tasks. The original scale was developed by Emde in 1989 and revised by Zeanah in 1997. The short form was developed by Van Rijen in 2014 and the Turkish validity and reliability study was conducted by Özkan Kunduracı and Aksoy in 2021.

The scale consists of four subscales: care and involvement, discipline, play, and routines. It includes items rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree).

The total score reflects the level of parenting self-efficacy, with higher scores indicating higher perceived competence and confidence in parenting roles, while lower scores indicate lower self-efficacy.

The reported internal consistency reliability (Cronbach's alpha) is 0.88.

From enrollment to the end of the 3-month follow-up period after the intervention
Infant-Toddler Home Observation for Measurement of the Environment (IT-HOME) Inventory
Prazo: From enrollment to the end of the 3-month follow-up period after the intervention

The Infant-Toddler Home Observation for Measurement of the Environment (IT-HOME) Inventory is used to assess the quality of the home environment that supports child development in infants and toddlers aged 3-36 months. The original scale was developed by Bradley and Caldwell in 1965 and updated by the National Institute of Child Health and Human Development (NICHD) in 2003. The Turkish validity and reliability study was conducted by Fındık and Aral in 2023.

The scale consists of 45 items across six subscales: responsivity (11 items), acceptance (8 items), organization (6 items), learning materials (9 items), involvement (6 items), and variety (5 items). Each item is scored dichotomously as Yes or No.

The total score ranges from 0 to 45, with higher scores indicating a higher quality home environment that is more supportive of child development. Lower scores indicate a less stimulating and less supportive home environment.

The scale is administered through observation and/or intervi

From enrollment to the end of the 3-month follow-up period after the intervention

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

1 de setembro de 2026

Conclusão Primária (Estimado)

31 de dezembro de 2026

Conclusão do estudo (Estimado)

30 de junho de 2028

Datas de inscrição no estudo

Enviado pela primeira vez

10 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

15 de junho de 2026

Primeira postagem (Real)

18 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

15 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • ErciyesU-SBF-PA-01
  • Assoc. Prof. Dr. Yağmur Sezer (Outro identificador: Erciyes University)

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Individual participant data will not be shared in order to protect participant confidentiality and ensure privacy. All collected data will be anonymized and reported only in aggregate form. Individual-level data sharing is not planned due to ethical and data protection considerations.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Ensaios clínicos em Desenvolvimento e Saúde

Se inscrever